← Eichor
Study identifier: NCT03807310 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Targeted Nutrient Supplement in COPD (NUTRECOVER-trial)

Condition: Pulmonary Disease, Chronic Obstructive  ·  Sponsor: Maastricht University Medical Center

PhaseNA
Planned participants166
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The overall objective is to investigate the efficacy of targeted nutrient supplementation on daily physical activity level as well as generic health status in patients with COPD. Additionally the investigators aim to investigate the relative effect of targeted nutrient supplementation on the recovery after hospitalization for a COPD exacerbation. The secondary objective is to investigate the effect of targeted nutrient supplementation on mental health, physical performance, blood markers, patient related outcomes and gut health. Additionally, a secondary objective is to compare the gut microbiome composition of patients with COPD compared to healthy controls.

This description comes directly from the study's public registry record.

Talk to the study team

Rosanne Beijers, Dr  ·  +31433882990  ·  r.beijers@maastrichtuniversity.nl

Harry Gosker, Dr  ·  +31433884298  ·  h.gosker@maastrichtuniversity.nl

Always discuss trial participation with your own doctor first.

Locations (1)

Maastricht University Medical Centre+ (MUMC+)Maastricht, Limburg, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03807310